← Leaderboards
Marcus Kaul
Burnham Institute For Medical Research
$16,863,032
Attributed
$17,212,227
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,212,227 · 10
By mechanism
R01$15,481,086 · 7
P50$1,334,871 · 1
R03$376,270 · 1
R13$20,000 · 1
Top collaborators
- Irene Munk Pedersen1 shared
Most similar at Burnham Institute For Medical Research
Same institution · by research overlap
- Stuart A Lipton$72,210,518
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectInfectionHiv-1Acquired Immunodeficiency SyndromeMacrophageIn VivoMicrogliaHiv Envelope Protein Gp120BrainMouse ModelSignal TransductionIn VitroNeurotoxicityNeuronsMolecularBehavioralLinkPreventNeurotoxicTransgenic MiceIn Vitro ModelProductionPerformanceCells
Grant awards (42)
Methamphetamine and Cysteinyl Leukotrienes in HIV Persistence$804,728
R01 · FY2025 · DA · contact PI
Harnessing Innate Immunity to Control the Neuroinflammatory HIV Reservoir$698,390
R01 · FY2025 · NS · contact PI
Methamphetamine Effect on HIV Persistence$619,818
R01 · FY2024 · DA · contact PI
Methamphetamine Effect on HIV Persistence$612,592
R01 · FY2023 · DA · contact PI
Methamphetamine Effect on HIV Persistence$659,864
R01 · FY2022 · DA · contact PI
Methamphetamine Effect on HIV Persistence$643,403
R01 · FY2021 · DA · contact PI
Methamphetamine Effect on HIV Persistence$646,948
R01 · FY2020 · DA · contact PI
Neuroprotection by IFN-beta in AIDS$513,304
R01 · FY2019 · MH · contact PI
Lipocalin-2 in HIV-Associated Neuronal Injury$388,750
R01 · FY2019 · MH · contact PI
Cysteinyl Leukotrienes in HIV Brain Injury$318,077
R01 · FY2019 · MH · contact PI
25th SNIP Scientific Conference$10,000
R13 · FY2019 · DA · contact PI
Neuroprotection by IFN-beta in AIDS$393,143
R01 · FY2018 · MH · contact PI
Lipocalin-2 in HIV-Associated Neuronal Injury$388,021
R01 · FY2018 · MH · contact PI
Cysteinyl Leukotrienes in HIV Brain Injury$270,234
R01 · FY2018 · MH · contact PI
HIV and Methamphetamine-Associated Alterations of Behavior and Neural Networks$243,520
P50 · FY2018 · DA · contact PI
24th SNIP Conference held jointly with Intl. Symp. on NeuroVirology$10,000
R13 · FY2018 · DA · contact PI
Neuroprotection by IFN-beta in AIDS$585,787
R01 · FY2017 · MH · contact PI
Lipocalin-2 in HIV-Associated Neuronal Injury$487,500
R01 · FY2017 · MH · contact PI
Cysteinyl Leukotrienes in HIV Brain Injury$271,297
R01 · FY2017 · MH · contact PI
HIV and Methamphetamine-Associated Alterations of Behavior and Neural Networks$243,519
P50 · FY2017 · DA · contact PI
Cysteinyl Leukotrienes in HIV Brain Injury$223,929
R01 · FY2017 · MH · contact PI
Neuroprotection by IFN-beta in AIDS$57,906
R01 · FY2017 · MH · contact PI
Neuroprotection by IFN-beta in AIDS$643,693
R01 · FY2016 · MH · contact PI
Lipocalin-2 in HIV-Associated Neuronal Injury$487,500
R01 · FY2016 · MH · contact PI
Cysteinyl Leukotrienes in HIV Brain Injury$438,750
R01 · FY2016 · MH · contact PI
HIV and Methamphetamine-Associated Alterations of Behavior and Neural Networks$241,084
P50 · FY2016 · DA · contact PI
Neuroprotection by IFN-beta in AIDS$715,213
R01 · FY2015 · MH · contact PI
Cysteinyl Leukotrienes in HIV Brain Injury$487,500
R01 · FY2015 · MH · contact PI
Lipocalin-2 in HIV-Associated Neuronal Injury$487,500
R01 · FY2015 · MH · contact PI
HIV and Methamphetamine-Associated Alterations of Behavior and Neural Networks$349,478
P50 · FY2015 · DA · contact PI
Neuroprotection by IFN-beta in AIDS$458,494
R01 · FY2014 · MH · contact PI
HIV and Methamphetamine-Associated Alterations of Behavior and Neural Networks$257,270
P50 · FY2014 · DA · contact PI
Neuroprotection by IFN-beta in AIDS$440,154
R01 · FY2013 · MH · contact PI
Neuroprotection by IFN-beta in AIDS$449,089
R01 · FY2012 · MH · contact PI
Neuroprotection by IFN-beta in AIDS$449,089
R01 · FY2011 · MH · contact PI
Combined effect of Methamphetamine, HIV and HAART on neurons and macrophages$185,270
R03 · FY2011 · DA · contact PI
Neuroprotection by IFN-beta in AIDS$453,625
R01 · FY2010 · MH · contact PI
Combined effect of Methamphetamine, HIV and HAART on neurons and macrophages$191,000
R03 · FY2010 · DA · contact PI
Chemokine Receptor Signaling in HIV Neuropathology$335,041
R01 · FY2007 · NS · contact PI
Chemokine Receptor Signaling in HIV Neuropathology$345,047
R01 · FY2006 · NS · contact PI
Chemokine Receptor Signaling in HIV Neuropathology$353,350
R01 · FY2005 · NS
Chemokine Receptor Signaling in HIV Neuropathology$353,350
R01 · FY2004 · NS